Critics oppose FDA approval of painkiller Zohydro
A new narcotic painkiller is due to come on the market in March, and critics want the FDA to reverse its approval of the drug, Zohydro ER. They claim it could become the next OxyContin, another opioid that's become a popular drug of abuse. Critics of the FDA's ruling include attorneys general from 28 states and FED UP!, a union of consumer groups, addiction treatment providers, drug and alcohol prevention programs and other interested groups.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063